The South African Health Products Regulatory Authority has reported a second death following vaccination with the Johnson & Johnson COVID-19 vaccine.
According to Sahpra, Guillain-Barré syndrome (GBS) is a rare but potentially severe neurological adverse event that is associated with the administration of various vaccines and other medicines.
In August, the country recorded its first fatality linked to taking the jab.
The second fatality, which was reported last month, was investigated by the National Immunisation Safety Expert Committee.
It found the patient’s demise as a result of GBS can be tied to taking the Johnson & Johnson vaccine.
In many cases, the condition resolves with no serious after-effects, but in some severe instances, it can cause serious or life-threatening problems.
More Stories
Matters Related To Putin Not On BRICS Meeting Agenda – Pandor
Professor Taole Mokoena appointed As SA’s New Health Ombudsman
Glencore Ferroalloys Supports Local SMME In Steelpoort With Two 65-Seater Busses
Car-Sharing Could Hold The Key To The Future Of SA’s Mobility In Urban Areas
Debt Ceiling Deal Wins House Approval
SA’s Health System A ‘Dysfunctional Mess’ That Can’t Be Fixed – Makgoba
Zimbabweans In SA Have A Month To Find Alternative Ways To Regularise Stay
Power Grid Collapse ‘Highly Improbable’ – Ramokgopa
Government Is Intensifying The Fight Against Crime – Ramaphosa
Ending Loadshedding Is Ramaphosa’s Top Priority
HEALA Urges SA Public To Comment On Draft Food Labelling Regulations
There’s Been An Improvement in Implementation Of Energy Action Plan – Ramokgopa